
Examining Impact of Crossover in the TRANSFORM Study of CAR T in LBCL
Nathan M. Denlinger, DO, MS Assistant Professor Division of Hematology The Ohio State University College of Medicine Columbus, OH Targeted Oncology: Can you describe the TRANSFORM study (NCT03575351) of chimeric antigen receptor (CAR) T-cell therapy and …